Robert Reiberger

Mr. Robert Reiberger

Institute of Organic Chemistry and Biochemistry CAS
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
ZOZuzana Osifová
Zuzana Osifová
Robert ReibergerRobert Reiberger
Robert Reiberger
ICIvana Císařová
Ivana Císařová
AMAleš Machara
Aleš Machara
MDMartin Dracinsky
Martin Dracinsky

Verified
Journal Article
Open access
PDF file
Robert ReibergerRobert Reiberger
Robert Reiberger
Katerina RadilovaKaterina Radilova
Katerina Radilova
MKMichal Kráľ
Michal Kráľ
VZVáclav Zima
Václav Zima
PMPavel Majer
Pavel Majer
AMAleš Machara
Aleš Machara
The part of the influenza polymerase PA subunit featuring endonuclease activity is a target for anti-influenza therapies, including the FDA-approved drug Xofluza. A general feature of endonuclease inhibitors is their ability to chelate Mg2+ or Mn2+ ions located in the enzyme’s catalytic site. Previously, we screened a panel of flavonoids for PA inhibition and found luteolin and its C-glucoside orientin to be potent inhibitors. Through structural analysis, we identified the presence of a 3′,4′-dihydroxyphenyl moiety as a crucial feature for sub-micromolar inhibitory activity. Here, we report results from a subsequent investigation exploring structural changes at the C-7 and C-8 positions of luteolin. Experimental IC50 values were determined by AlphaScreen technology. The most potent inhibitors were C-8 derivatives with inhibitory potencies comparable to that of luteolin. Bio-isosteric replacement of the C-7 hydroxyl moiety of luteolin led to a series of compounds with one-order-of-magnitude-lower inhibitory potencies. Using X-ray crystallography, we solved structures of the wild-type PA-N-terminal domain and its I38T mutant in complex with orientin at 1.9 Å and 2.2 Å resolution, respectively.

16 September 2021 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
MKMartin Kamlar
Martin Kamlar
Robert ReibergerRobert Reiberger
Robert Reiberger
MNMartin Nigríni
Martin Nigríni
ICIvana Císařová
Ivana Císařová
JVJan Veselý
Jan Veselý
Here we present an enantioselective aminalization of aldehydes catalyzed by Brønsted acids based on pentacarboxycyclopentadienes (PCCPs). The cyclization reaction using readily available anthranilamides as building blocks provides access to valuable 2,3-dihydroquinazolinones containing one stereogenic carbon center with good enantioselectivity (ee up to 80%) and excellent yields (up to 97%).

11 March 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
Robert ReibergerRobert Reiberger
Robert Reiberger
MKMichal Kráľ
Michal Kráľ
KRKateřina Radilová
Kateřina Radilová
TKTomáš Kotačka
Tomáš Kotačka
MDMartin Dracinsky
Martin Dracinsky
AMAleš Machara
Aleš Machara
Scaffold-hopping from luteolin led to a new class of submicromolar pseudoflavonoid-based influenza endonuclease inhibitors. A novel binding mode of compound 36 was observed in the PA-Nter active site.

11 November 2024 in ChemMedChem
Verified
Journal Article
Open access
MKMichal Kráľ
Michal Kráľ
TKTomáš Kotačka
Tomáš Kotačka
Robert ReibergerRobert Reiberger
Robert Reiberger
GPGabriela Panýrková
Gabriela Panýrková
Katerina RadilovaKaterina Radilova
Katerina Radilova
AMAleš Machara
Aleš Machara
The influenza RNA‐dependent RNA polymerase harbours an endonuclease subunit characterized by a catalytic site housing two divalent metal ions. By effectively chelating both Mg2+ and Mn2+ ions, a small‐molecule inhibitor with a metal‐binding pharmacophore can halt endonuclease activity. Herein, two 3’‐dehydroxypurpurogallin‐4‐carboxamide series, namely twelve C‐4’ unsubstituted and twelve C‐4’ phenyl substituted congeners were designed and prepared to be tested as inhibitors of the metal‐dependent viral enzyme. These inhibitors were accessed through the chemoenzymatic reaction of gallic acid with either pyrocatechol or phenylpyrocatechol moderated by laccase, followed by amidation. Experimental IC50 values were determined using AlphaScreen technology, with the most potent inhibitors exhibiting IC50 values around 0.35 μM. Using X‐ray crystallography, we analyzed structure of the endonuclease in complex with one potent 3’‐dehydroxypurpurogallin‐carboxamide at 2.0 Å resolution, revealing the coordination of the compound's triad of oxygen atoms with the two metal ions in the influenza A endonuclease active site.